Internal Medicine, Rheumatology · Grapevine, TX
NPI
1174562565
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1501 W Northwest Hwy
Grapevine, TX, 76051
Phone (817) 416-7695
Groups this clinician bills Medicare through
Medicare paid, 2024
$829K
98,900 services
Medicare patients, 2024
377
Average age 73
Drug cost, 2024
$1.5M
3,308 prescriptions
Company payments, 2025
$2,103
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Uzma A Syeda was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 64,800 times for 21 patients. In total Uzma A Syeda billed 98,900 services in 32 codes, and Medicare paid $829K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 64,800 | 21 | $3.61 | $234K |
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 31 | $20.57 | $57K |
| 99214 Office E&M - Established | Office | 761 | 337 | $96.87 | $74K |
| 96401 Chemotherapy Administration | Office | 417 | 53 | $60.04 | $25K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 324 | 12 | $0.11 | $34.07 |
| 96413 Chemotherapy Administration | Office | 173 | 30 | $107.04 | $19K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 145 | 27 | $0.70 | $101 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 100 | 20 | $5.18 | $518 |
| 99204 Office E&M - New | Office | 74 | 74 | $122.71 | $9,080 |
| 99205 Office E&M - New | Office | 32 | 32 | $177.45 | $5,678 |
| 99215 Office E&M - Established | Office | 32 | 21 | $135.38 | $4,332 |
| 96365 Intravenous Infusion, Hydration | Office | 20 | 20 | $52.60 | $1,052 |
| 20610 Joint Injection | Office | 18 | 14 | $51.69 | $930 |
| 20600 Joint Injection | Office | 16 | 13 | $37.66 | $603 |
| 96372 Injection Administration | Office | 14 | 14 | $12.06 | $169 |
By year: 2022 $802K for 92,258 services; 2023 $704K for 85,511 services; 2024 $829K for 98,900 services.
Medicare prescription drug claims, 2024
In 2024, the drug Uzma A Syeda prescribed most often to Medicare patients was Prednisone, with 483 prescriptions and refills. In total Uzma A Syeda wrote 3,308 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 483 | 560 | 113 | $2,751 |
| Hydroxychloroquine Sulfate Generic | 316 | 600 | 87 | $8,840 |
| Methotrexate Methotrexate Sodium | 279 | 412 | 80 | $2,980 |
| Duloxetine Hcl Generic | 229 | 376 | 57 | $3,228 |
| Gabapentin Generic | 218 | 313 | 70 | $2,506 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 192 | 192 | 58 | $3,592 |
| Allopurinol Generic | 162 | 334 | 48 | $818 |
| Pregabalin Generic | 157 | 208 | 40 | $2,716 |
| Tramadol Hcl Generic | 110 | 110 | 18 | $1,206 |
| Folic Acid Generic | 80 | 175 | 23 | $584 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 62 | 62 | 14 | $1,424 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 55 | 91 | 12 | $434 |
| Ibandronate Sodium Generic | 55 | 93 | 16 | $921 |
| Alendronate Sodium Generic | 54 | 120 | 19 | $306 |
| Meloxicam Generic | 45 | 48 | Under 11 | $133 |
Brand drugs: - claims; generic drugs: 2,957 claims; opioid claims: 364.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Uzma A Syeda $2,103 ($2,103 in general payments such as food, travel and fees) from 16 companies. The largest payer was UCB, Inc. with $351.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 9 | $351 |
| Amgen Inc. AMGN | 23 | $349 |
| Janssen Biotech, Inc. JNJ | 10 | $349 |
| GlaxoSmithKline, LLC. GSK | 7 | $247 |
| Abbvie Inc. ABBV | 10 | $230 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $221 |
| Radius Health, Inc. | 3 | $70.55 |
| Genzyme Corporation SNY | 2 | $53.77 |
| Organon LLC OGN | 3 | $49.68 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $43.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.